openPR Logo
Press release

Psychiatric Disorder Indication Vocal Biomarker Market to Generate 130 Mn Revenues by 2027-end | Beyond Verbal, Sonde Health, IBM Corporation

05-04-2021 09:31 PM CET | Health & Medicine

Press release from: Fact.MR

According to a recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease diagnostics including psychiatric and cardiovascular ailments.

Click here to Get Complete Synopsis of the Report – https://www.factmr.com/report/719/vocal-biomarker-market

Post-successful execution of clinical trials, HIPAA-compliant vocal biomarkers are set to serve as effective alternatives to currently available disease diagnostic systems such as CT scan, MRI and X-ray.

Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example – Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 Mn samples of voice in more than 40 different languages.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=719

Site Management by CROs Essential for Ensuring Vocal Biomarker Clinical Trails’ Success

Contract research organizations (CROs) are likely to spearhead the global vocal biomarker market, in terms of revenues as well as growth rate. Given the expanding range of voice-assistant, health-related applications, life sciences and healthcare organizations have commenced designing an array of scenarios to deploy voice assistant platforms in clinical trial settings. Integration of these platforms in the research for vocal biomarkers has the potential to address specific drawbacks in current clinical trial environment.

CROs are essential and play a key role in ensuring the clinical trials’ success through proper site management. Accurate level of site management & oversight prompts site to effectively recruit, train, and retain subjects, meanwhile ensuring overall management of subjects, protocol adherence, and regulatory compliance.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=719

CROs help in maintaining and improving the communication flow, thereby reducing protocol deviations & violations, and addressing data issues & queries. These benefits of CROs also effectively apply to quality and integrity of clinical trials apropos of vocal biomarkers.

Non-invasiveness of Vocal Biomarker in Psychiatric Disorder Diagnostics in Sync with Self-diagnosis’ Upward Trend

Sound vibrations have been employed as biomarkers for diagnosing psychiatric disorders such as depression and anxiety. Similar distinctive features, known as vocal biomarkers, have been recently discovered by scientists that might pose a massive influence on developing a diagnostic tool. Additionally, latest research analyses have greatly impacted application of vocal biomarkers in diagnosing psychiatric ailments ranging from stress to Parkinson’s disease.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/719/S

Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impracticable for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders.

Moreover, these significant user-friendly tools fall perfectly in line with the upward trend of self-diagnosis, which in turn has considerably fuelled their demand across the globe. Psychiatric disorders are likely to remain the leading indication in the global vocal biomarker market, with revenues estimated to rake in approximately US$ 130 Mn by 2027-end.

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=719

Fact.MR’s report foresees the global market for vocal biomarker to reflect a staggering expansion in the period of forecast, 2018 to 2027. Over US$ 390 Mn worth of vocal biomarkers are envisaged to be sold across the globe by 2027-end.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/719/vocal-biomarker-market
Content Source: https://www.factmr.com/media-release/472/vocal-biomarker-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psychiatric Disorder Indication Vocal Biomarker Market to Generate 130 Mn Revenues by 2027-end | Beyond Verbal, Sonde Health, IBM Corporation here

News-ID: 2279904 • Views: 275

More Releases from Fact.MR

Organic Sulfur Market Global Demand, Growth, Opportunities, Top Key Players and …
Fact.MR has adopted multi-disciplinary approach to shed light on the keyword during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year, and key prospects over the forecast period 2018-2028. The insights and analytics on the Organic Sulfur Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment,
GLA Supplements Market Key Players, SWOT Analysis, Dynamics, Drivers, Key Indica …
Fact.MR has adopted multi-disciplinary approach to shed light on the GLA Supplements during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year, and key prospects over the forecast period 2018-2028. The insights and analytics on the GLA Supplements Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity
Global Electrotechnical Paper Market to Create an Absolute Dollar Opportunity of …
The recently published market study by Fact.MR highlights the current trends that are expected to influence the dynamics of the Electrotechnical Paper Market in the upcoming years. Click here to Get Complete Synopsis of the Report – https://www.factmr.com/report/1956/electrotechnical-paper-market The report introspects the supply chain, cost structure, and recent developments pertaining to the Electrotechnical Paper Market in the report and the impact of the COVID-19 on these facets of the market. Further,
Global Dibenzyl Toluene Marke to Expand 1.4X by 2030 end | Eastman Chemicals, Ar …
The recently published market study by Fact.MR highlights the current trends that are expected to influence the dynamics of the Dibenzyl Toluene Market in the upcoming years. Click here to Get Complete Synopsis of the Report - https://www.factmr.com/report/4843/dibenzyl-toluene-market   The report introspects the supply chain, cost structure, and recent developments pertaining to the Dibenzyl Toluene Market in the report and the impact of the COVID-19 on these facets of the market. Further,

All 5 Releases


More Releases for CROs

Global CROs Services Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on CROs Services Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/435591/global-cros-services-market-insights   A contract research organization (CRO) is a company that
Contract Research Organization Services (CROs) Market brisk growth 2025
Contract Research Organization Services (CROs): Snapshot Contract Research Organization or CRO is described as an organization which provide assistance and services generally to the pharmaceutical and biotechnology industries in the form of data research, drug tests, clinical trials, post development marketing, and related services for the development of both drugs and medical devices. CROs are available in a vast range from large, international full service organizations to small, niche specialty groups
Global Contract Research Organizations (CROs) Services Market Research Report 20 …
ResearchMoz added Latest Research Report titled " Global Contract Research Organizations (CROs) Services Market Research Report 2016 " to it's Large Report database. Notes: Production, means the output of Contract Research Organizations (CROs) Services Revenue, means the sales value of Contract Research Organizations (CROs) Services This report studies Contract Research Organizations (CROs) Services in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market,
11-26-2010 | Health & Medicine
CROS NT
CROS NT WINS A "BEST PRESENTATION" AT PhUSE 2010
Verona, Italy (26 NOVEMBER 2010) – Stefano Vezzoli, part of CROS NT’s highly qualified and experienced biostatistics team, won Best Presentation in the area of Statistics and Pharmacokinetics at the Pharmaceutical Users Software Exchange (PhUSE) conference in Berlin, Germany. Vezzoli’s presentation was titled “Inference for the Location Shift in 3x3 Crossover Studies: the Median-Scaling Method”. Vezzoli’s Paper Abstract In the case of non-normal study outcomes, a nonparametric approach may be used
11-23-2010 | Health & Medicine
CROS NT
CROS NT GROUP TO ATTEND THIRD ANNUAL ONCOLOGY CLINICAL TRIALS
Verona, Italy (23 NOVEMBER 2010) – The German subsidiary of the CROS NT Group, CROS DE GmbH, will be present at the Third Annual Oncology Clinical Trials in Munich, Germany from 29 November through 1 December. The therapeutic area of oncology is one of CROS NT’s areas of excellence regarding clinical trial experience, and the CROS DE management team is at the forefront of clinical trial consultancy in this field.
07-29-2010 | Health & Medicine
CROS NT
CROS NT appoints new Vice President for Germany
CROS NT (CRO) announces the appointment of Frank Freischläger as Vice President (VP) for CROS DE GmbH, the German affiliate of CROS NT. As a VP at CROS DE he will be responsible for all aspects, which is focused on successful clinical trial activities. CROS is very excited to adding Mr. Freischläger's depth of industry expertise to the CROS team. "Bringing someone of Frank's knowledge to an already strong team